S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Celator® Pharmaceuticals Announces Publication Of Promising Phase 2 Data For CPX-351 In First Relapse Acute Myeloid Leukemia Patients (2015/1/12)|
|Celator® Pharmaceuticals Presents Data on CPX-351 at the 56th American Society of Hematology Annual Meeting (2014/12/10)|
|Celator® Pharmaceuticals Announces Data And Safety Monitoring Board Recommendation To Continue Phase 3 Study Of CPX-351 (2014/12/1)|
|Celator® Pharmaceuticals Receives FDA Fast Track Designation For CPX-351 For The Treatment Of Elderly Patients With Secondary Acute Myeloid Leukemia (2015/1/20)|
|Celator® Pharmaceuticals Receives $1,937,000 from New Jersey's Technology Business Tax Certificate Transfer Program (2015/1/5)|
|Celator® Pharmaceuticals Receives European Patent Allowance on Nanoparticle Delivery Technology (2014/12/18)|
|Full Circle Capital Provides Update on Second Quarter 2015 Portfolio Activity (2015/1/15)|
Click above to view more mutual fund data and stats for cpx - CAP-XX Ltd.